SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sophiris Bio Inc. Announces 12 Month Follow-Up Data From Phase 2b TRIUMPH Clinical Trial of PRX302 in Patients With Benign Prostatic Hyperplasia